Suchergebnisse - "Prudkin, L."

PubPharm (14)

1

Use of Topical Corticosteroids in the Treatment of Noninfectious Inflammatory Dermatoses of the Scalp: A Survey of Practicing Dermatologists and Dermatology Residents Using Delphi Methodology

in: Clinical, Cosmetic and Investigational Dermatology | 2024

von Mir-Bonafé JF | Piquero-Casals J | Prudkin L | +3

2

Lurbinectedin (PM01183) exhibits antitumor activity in PARP-inhibitor resistant germline BRCA PDX and lacks cross-resistance with cisplatin

enthalten in: Annals of oncology | 2016

von Cruz, C. | Caratu, G. | Llop-Guevara, A. | +15

3

Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Nuciforo, P. | Aura, C. | Holmes, E. | +10

4

Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Alsina, M. | Landolfi, S. | Aura, C. | +8

5

Cyclin E amplification/overexpression is associated with poor prognosis in gastric cancer

enthalten in: Annals of oncology | 2015

von Alsina, M. | Landolfi, S. | Aura, C. | +8

6

Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status

enthalten in: Annals of oncology | 2015

von Nuciforo, P. | Aura, C. | Holmes, E. | +10

7

359 Tumor Pharmacodynamic Assessments by Reverse Phase Protein Array Reveal Broad Pathway Inhibition in Patients Treated with an AKT Kinase Inhibitor

enthalten in: The European journal of cancer / A | 2012

von Yan, Y. | Serra, V. | Prudkin, L. | +7

8

Developmental therapeutics

enthalten in: Annals of oncology | 2012

von Felip, E. | Carcereny, E. | Barlesi, F. | +96

9

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

enthalten in: Oncogene | 2011

von Serra, V. | Scaltriti, M. | Prudkin, L. | +14

10

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

enthalten in: Oncogene | 2011

von Serra, V. | Scaltriti, M. | Prudkin, L. | +14